Sunshine Biopharma Inc (SBFM) Company Profile & Statistics

Sunshine Biopharma Inc
SBFM
(Nasdaq - US)
Closed
1.23
-0.21 (-14.58%)
in:usd•As of: Apr 23, 2024 15:59 UTC -4
After Market:1.19-0.04 (-3.25%)
Open
1.28
High
1.28
Low
1.16

About Sunshine Biopharma Inc

CEO

Steve N. Slilaty

Headquarters

1177 avenue of the americas,5th floor

new york, ny 10036, united states

Auditor

BF Borgers CPA PC

Employees

Share Holders

149

Website

https://sunshinebiopharma.com/

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Sunshine Biopharma Inc. is a pharmaceutical company. It focused on the research, development and commercialization of oncology and antiviral drugs. Sunshine Biopharma Inc. is based in MONTREAL.

Sunshine Biopharma Inc Statistics

Valuation Measures

Market Capitalization ²	1.22M
Enterprise Value	-15.07M
Enterprise Value/EBITDA (ttm)	3.25
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.02
Price to Sales (ttm)	0.07
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	34.83%
Operating Margin (ttm)	-18.70%
Profit Margin (ttm)	-19.55%
Return on Equity (ttm)	-21.03%
Return on Invested Capital (ttm)	-21.53%
Return on Assets (ttm)	-16.32%

Income Statement

Revenue (ttm)	24.09M
Revenue Per Share (ttm)	0.24
Gross Profit (ttm)	8.34M
EBITDA (ttm)³	-4.64M
Net Income Avi to Common (ttm)	-4.51M
Diluted EPS (ttm)	-19.00

Share Statistics

Beta (5Y Monthly)	1.17
52-Week Change	-98.16%
S&P500 52-Week Change	22.56%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	99.45M
Dividend Yield	0.00%
Float ⁴	954.00K
% Held by Insiders	4.10%
% Held by Institutions	41.98%

Balance Sheet

Total Cash (mrq)	16.29M
Total Cash Per Share (mrq)	0.16
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	4.48%
Quick Ratio (mrq)	3.45%
Book Value Per Share (mrq)	0.76

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.36
Free Cash Flow (ytd)	-8.86M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Sunshine Biopharma Inc

Trade With A Regulated Broker